Estimated reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa

References

• Tate JE, Burton AH, Boschi-Pinto C, et al. Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000–2013. Clin Infect Dis. 2016;62:S96–S105.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Do M, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23–33. Epub 2006/01/06.
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11–22. Epub 2006/01/06.
   PubMed Web of Science ®Google Scholar
• Payne DC, Vinje J, Szilagyi PG, et al. Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med. 2013;368:1121–1130. Epub 2013/03/22.
   PubMed Web of Science ®Google Scholar
• Hemming M, Räsänen S, Huhti L, et al. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland. Eur J Pediatr. 2013;172:739–746.
   PubMed Web of Science ®Google Scholar
• Bucardo F, Reyes Y, Svensson L, et al. Predominance of norovirus and sapovirus in Nicaragua after implementation of universal rotavirus vaccination. PLoS One. 2014;9:e98201. Epub 2014/05/23.
   PubMed Web of Science ®Google Scholar
• Koo HL, Neill FH, Estes MK, et al. Noroviruses: the most common pediatric viral enteric pathogen at a Large University Hospital after introduction of rotavirus vaccination. J Pediatric Infect Dis Soc. 2013;2:57–60. Epub 2013/05/21.
   PubMedGoogle Scholar
• Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010 Epub 2010/01/29;362:289–298.
   PubMed Web of Science ®Google Scholar
• Armah GE, Sow SO, Breiman RF, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet (London, England). 2010 Epub 2010/08/10;376:606–614.
   PubMed Web of Science ®Google Scholar
• Zaman K, Dang DA, Victor JC, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet (London, England). 2010;376:615–623. Epub 2010/08/10.
   PubMed Web of Science ®Google Scholar
• Pasetti MF, Simon JK, Sztein MB, et al. Immunology of gut mucosal vaccines. Immunol Rev. 2011;239:125–148. Epub 2011/01/05.
   PubMed Web of Science ®Google Scholar
• Kosek M, Guerrant RL, Kang G, et al. Assessment of environmental enteropathy in the MAL-ED cohort study: theoretical and analytic framework. Clin Infect Diseases Off Publ Infect Dis Soc America. 2014;59:S239–S47.
   PubMed Web of Science ®Google Scholar
• Jiang V, Jiang B, Tate J, et al. Performance of rotavirus vaccines in developed and developing countries. Hum Vaccin. 2010;6:532–542.
   PubMed Web of Science ®Google Scholar
• Stelekati E, Wherry EJ. Chronic bystander infections and immunity to unrelated antigens. Cell Host Microbe. 2012;12:458–469. Epub 2012/10/23.
   PubMed Web of Science ®Google Scholar
• Naylor C, Lu M, Haque R, et al. Environmental enteropathy, oral vaccine failure and growth faltering in infants in Bangladesh. EBioMedicine. 2015;2:1759–1766. Epub 2016/02/13.
   PubMed Web of Science ®Google Scholar
• Moon SS, Tate JE, Ray P, et al. Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countries. Pediatr Infect Dis J. 2013;32:863–870. Epub 2013/04/16.
   PubMed Web of Science ®Google Scholar
• Emperador DM, Velasquez DE, Estivariz CF, et al. Interference of monovalent, bivalent, and trivalent oral poliovirus vaccines on monovalent rotavirus vaccine immunogenicity in rural Bangladesh. Clin Infect Dis. 2016;62:150–156. Epub 2015/09/10.
   PubMed Web of Science ®Google Scholar
• Ramani S, Mamani N, Villena R, et al. Rotavirus serum iga immune response in children receiving rotarix coadministered with bOPV or IPV. Pediatr Infect Dis J. 2016;35:1137–1139. Epub 2016/06/03.
   PubMed Web of Science ®Google Scholar
• Gessner BD, Feikin DR. Vaccine preventable disease incidence as a complement to vaccine efficacy for setting vaccine policy. Vaccine. 2014;32:3133–3138. Epub 2014/04/16.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Rotavirus vaccines: an update. Weekly Epidemiological Record. 2009;84:533–540. Epub 2009/12/26.
   PubMedGoogle Scholar
• Gavi: The Vaccine Alliance. Countries eligible for support; cited 2017 Mar 3. Available from: http://www.gavi.org/support/sustainability/countries-eligible-for-support/
   Google Scholar
• Nokes DJ, Abwao J, Pamba A, et al. Incidence and clinical characteristics of group A rotavirus infections among children admitted to hospital in Kilifi, Kenya. PLoS Med. 2008;5:e153.
   PubMed Web of Science ®Google Scholar
• Tate JE, Rheingans RD, O’Reilly CE, et al. Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in Kenya. J Infect Dis. 2009;200:S76–S84.
   PubMed Web of Science ®Google Scholar
• Khagayi S, Burton DC, Onkoba R, et al. High burden of rotavirus gastroenteritis in young children in rural western Kenya, 2010-2011. Pediatr Infect Dis J. 2014;33(Suppl 1):S34–40. Epub 2013/12/18.
   PubMed Web of Science ®Google Scholar
• Alkoshi S, Leshem E, Parashar UD, et al. Anticipating rotavirus vaccines–a pre-vaccine assessment of incidence and economic burden of rotavirus hospitalizations among children < 5 year of age in Libya, 2012-13. BMC Public Health. 2015;15:26. Epub 2015/01/27.
   PubMed Web of Science ®Google Scholar
• Bar-Zeev N, Jere KC, Bennett A, et al. Population impact and effectiveness of monovalent rotavirus vaccination in urban Malawian children 3 years after vaccine introduction: ecological and case-control analyses. Clin Infect Diseases: Off Publ Infect Dis Soc America. 2016;62:S213–S9.
   PubMed Web of Science ®Google Scholar
• Nhampossa T, Mandomando I, Acacio S, et al. Diarrheal disease in rural Mozambique: burden, risk factors and etiology of diarrheal disease among children aged 0–59 months seeking care at health facilities. Plos One. 2015;10:e0119824.
   PubMed Web of Science ®Google Scholar
• Seheri ML, Dewar JB, van der Merwe L, et al. Prospective hospital-based surveillance to estimate rotavirus disease burden in the Gauteng and North West Province of South Africa during 2003–2005. J Infect Dis. 2010;202:S131–S8.
   PubMed Web of Science ®Google Scholar
• Odhiambo FO, Laserson KF, Sewe M, et al. Profile: the KEMRI/CDC health and demographic surveillance system–Western Kenya. Int J Epidemiol. 2012;41:977–987. Epub 2012/08/31.
   PubMed Web of Science ®Google Scholar
• Global Burden of Disease Pediatrics Collaboration. Global and national burden of diseases and injuries among children and adolescents between 1990 and 2013: findings from the global burden of disease 2013 study. JAMA Pediatr. 2016;170(3):267–287.
   PubMed Web of Science ®Google Scholar
• Walker CL, Rudan I, Liu L, et al. Global burden of childhood pneumonia and diarrhoea. Lancet (London, England). 2013;381:1405–1416. Epub 2013/04/16.
   PubMed Web of Science ®Google Scholar
• Lanata CF, Fischer-Walker CL, Olascoaga AC, et al. Global causes of diarrheal disease mortality in children <5 years of age: a systematic review. PLoS One. 2013;8(9):e72788. doi: 10.1371/journal.pone.0072788.
   Web of Science ®Google Scholar
• United Nations Department of Economic and Social Affairs, Population Division. World Population Prospects: the 2015 Revision, DVD Edition. 2015; [cited 2017 Mar].
   Google Scholar
• World Health Organization. Child cause of death estimates 2000-2013; [ cited 2017 Mar]. Available from: http://www.who.int/healthinfo/global_burden_disease/estimates_child_cod_2013/en/
   Google Scholar
• Gastanaduy PA, Steenhoff AP, Mokomane M, et al. Effectiveness of monovalent rotavirus vaccine after programmatic implementation in Botswana: a multisite prospective case-control study. Clin Infect Dis. 2016;62(Suppl 2):S161–7. Epub 2016/04/10.
   PubMed Web of Science ®Google Scholar
• Ngabo F, Tate JE, Gatera M, et al. Effect of pentavalent rotavirus vaccine introduction on hospital admissions for diarrhoea and rotavirus in children in Rwanda: a time-series analysis. Lancet Glob Health. 2016;4:e129–36. Epub 2016/01/30.
   PubMed Web of Science ®Google Scholar
• Groome MJ, Moon SS, Velasquez D, et al. Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa. Bull World Health Organ. 2014;92:238–245. Epub 2014/04/05.
   PubMed Web of Science ®Google Scholar
• Abeid KA, Jani B, Cortese MM, et al. Monovalent rotavirus vaccine effectiveness and impact on rotavirus hospitalizations in Zanzibar. Tanzania: Data from the First 3 Years Post-Introduction. The Journal of infectious diseases; 2016. Epub 2016/11/07.
   Google Scholar
• Armah G, Pringle K, Enweronu-Laryea CC, et al. Impact and effectiveness of monovalent rotavirus vaccine against severe rotavirus diarrhea in Ghana. Clin Infect Dis. 2016;62(Suppl 2):S200–7. Epub 2016/04/10.
   PubMed Web of Science ®Google Scholar
• Bar-Zeev N, Kapanda L, Tate JE, et al. Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study. Lancet Infect Dis. 2015;15:422–428. Epub 2015/02/02.
   PubMed Web of Science ®Google Scholar
• Beres LK, Tate JE, Njobvu L, et al. A preliminary assessment of rotavirus vaccine effectiveness in Zambia. Clin Infect Dis. 2016;62(Suppl 2):S175–82. Epub 2016/04/10.
   PubMed Web of Science ®Google Scholar
• Tate JE, Patel MM, Cortese MM, et al. Use of patients with diarrhea who test negative for rotavirus as controls to estimate rotavirus vaccine effectiveness through case-control studies. Clin Infect Dis. 2016;62(Suppl 2):S106–14. Epub 2016/04/10.
   PubMed Web of Science ®Google Scholar
• Schwartz LM, Halloran ME, Rowhani-Rahbar A, et al. Rotavirus vaccine effectiveness in low-income settings: an evaluation of the test-negative design. Vaccine. 2017;35:184–190. Epub 2016/11/24.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO mortality database. Geneva, Switzerland; [ cited 2017 Mar]. Available from: http://www.who.int/healthinfo/mortality_data/en/
   Google Scholar
• World Health Organization. WHO vaccine-preventable diseases: monitoring system. Geneva, Switzerland; [ cited 2017 Mar]. Available from:http://www.who.int/immunization/monitoring_surveillance/data/en/
   Google Scholar
• World Health Organization. Recommendations for routine immunization - summary tables. Geneva, Switzerland; [ cited 2017 Mar]. Available from: http://www.who.int/immunization/policy/immunization_tables/en/
   Google Scholar
• De Oliveira LH, Danovaro-Holliday MC, Sanwogou NJ, et al. Progress in the introduction of the rotavirus vaccine in Latin America and the Caribbean: four years of accumulated experience. Pediatr Infect Dis J. 2011;30:S61–6. Epub 2011/01/12.
   PubMed Web of Science ®Google Scholar
• Progress in the introduction of rotavirus vaccine–Latin America and the Caribbean, 2006-2010. MMWR Morbidity and mortality weekly report. 2011;60:1611–1614. Epub 2011/12/02.
   Google Scholar
• World Health Organization. Global vaccine action plan 2011-2020. Geneva, Switzerland; [ cited 2017 Mar]. Available from: http://www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_2011_2020/en/
   Google Scholar
• United Nations Department of Economic and Social Affairs, Statistics Division. Composition of macro geographical (continental) regions, geographical sub-regions, and selected economic and other groupings; [ cited 2017 Mar]. Available from: https://millenniumindicators.un.org/unsd/methods/m49/m49regin.htm#africa
   Google Scholar
• The World Bank. World Bank Country and Lending Groups; [ cited 2017 Mar]. Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups
   Google Scholar
• Parashar UD, Hummelman EG, Bresee JS, et al. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 2003;9:565–572. Epub 2003/05/10.
   PubMed Web of Science ®Google Scholar
• Breiman RF, Zaman K, Armah G, et al. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine. Vaccine. 2012;30(Suppl 1):A24–9. Epub 2012/05/02.
   PubMed Web of Science ®Google Scholar
• Feikin DR, Laserson KF, Ojwando J, et al. Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya. Vaccine. 2012;30(Suppl 1):A52–60. Epub 2012/05/02.
   PubMed Web of Science ®Google Scholar
• Colgate ER, Haque R, Dickson DM, et al. Delayed dosing of oral rotavirus vaccine demonstrates decreased risk of rotavirus gastroenteritis associated with serum zinc: a randomized controlled trial. Clin Infect Dis. 2016;63:634–641. Epub 2016/05/25.
   PubMed Web of Science ®Google Scholar
• Ali A, Kazi AM, Cortese MM, et al. Impact of withholding breastfeeding at the time of vaccination on the immunogenicity of oral rotavirus vaccine–a randomized trial. PLoS One. 2015;10:e0127622. Epub 2015/06/04.
   PubMed Web of Science ®Google Scholar
• Rongsen-Chandola T, Strand TA, Goyal N, et al. Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants. Vaccine. 2014;32(Suppl 1):A134–9. Epub 2014/08/06.
   PubMed Web of Science ®Google Scholar
• Tissera MS, Cowley D, Bogdanovic-Sakran N, et al. Options for improving effectiveness of rotavirus vaccines in developing countries. Hum Vaccin Immunother. 2017;13(4):921–927.
   PubMed Web of Science ®Google Scholar
• Burnett E, Yen C, Tate JE, et al. Rotavirus vaccines: current global impact and future perspectives. Future Virol. 2016;11:699–708.
   PubMed Web of Science ®Google Scholar
• Restrepo-Mendez MC, Barros AJ, Wong KL, et al. Inequalities in full immunization coverage: trends in low- and middle-income countries. Bull World Health Organ. 2016;94:794–805b. Epub 2016/11/09.
   PubMed Web of Science ®Google Scholar
• Rheingans R, Atherly D, Anderson J. Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness. Vaccine. 2012;30(Suppl 1):A15–23. Epub 2012/05/02.
   PubMed Web of Science ®Google Scholar
• Bines JE, Patel M, Parashar U. Assessment of postlicensure safety of rotavirus vaccines, with emphasis on intussusception. J Infect Dis. 2009;200(Suppl 1):S282–90. Epub 2009/10/13.
   PubMed Web of Science ®Google Scholar
• Mandomando I, Weldegebriel G, de Deus N, et al. Feasibility of using regional sentinel surveillance to monitor the rotavirus vaccine impact, effectiveness and intussusception incidence in the African Region. Vaccine. 2017;35:1663–1667, Epub 2017/03/01
   PubMed Web of Science ®Google Scholar
• Mwenda JM, Tate JE, Steele AD, et al. Preparing for the scale-up of rotavirus vaccine introduction in Africa: establishing surveillance platforms to monitor disease burden and vaccine impact. Pediatr Infect Dis J. 2014;33(Suppl 1):S1–5. Epub 2013/12/18.
   PubMed Web of Science ®Google Scholar
• Mpabalwani EM, Mwenda JM, Tate JE, et al. Review of naturally occurring intussusception in young children in the WHO African region prior to the era of rotavirus vaccine utilization in the expanded programme of immunization. J Trop Pediatr. 2017;63:221–228. Epub 2016/10/04.
   PubMed Web of Science ®Google Scholar
• Tate JE, Parashar UD. Rotavirus vaccines in routine use. Clin Infect Dis. 2014;59:1291–1301. Epub 2014/07/23.
   PubMed Web of Science ®Google Scholar
• Yen C, Tate JE, Hyde TB, et al. Rotavirus vaccines: current status and future considerations. Hum Vaccin Immunother. 2014;10:1436–1448. Epub 2014/04/24.
   PubMed Web of Science ®Google Scholar
• Bhandari N, Rongsen-Chandola T, Bavdekar A, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet (London, England). 2014;383:2136–2143. Epub 2014/03/19.
   PubMed Web of Science ®Google Scholar
• Isanaka S, Guindo O, Langendorf C, et al. Efficacy of a low-cost, heat-stable oral rotavirus vaccine in Niger. New England J Med. 2017;376:1121–1130.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Immunization standards: vaccine quality. Geneva, Switzerland; [ cited 2017 Mar]. Available from: http://www.who.int/immunization_standards/vaccine_quality/en/
   Google Scholar
• Fix AD, Harro C, McNeal M, et al. Safety and immunogenicity of a parenterally administered rotavirus VP8 subunit vaccine in healthy adults. Vaccine. 2015;33:3766–3772. Epub 2015/06/13.
   PubMed Web of Science ®Google Scholar
• Kang G, Thuppal SV, Srinivasan R, et al. Racecadotril in the management of rotavirus and non-rotavirus diarrhea in under-five children: two randomized, double-blind, placebo-controlled trials. Indian Pediatr. 2016;53:595–600. Epub 2016/08/11.
   PubMed Web of Science ®Google Scholar
• Gharial J, Laving A, Were F. Racecadotril for the treatment of severe acute watery diarrhoea in children admitted to a tertiary hospital in Kenya. BMJ. 2017;4:e000124. Epub 2017/01/27.
   Web of Science ®Google Scholar
• Armah G, Lewis KD, Cortese MM, et al. A randomized, controlled trial of the impact of alternative dosing schedules on the immune response to human rotavirus vaccine in rural Ghanaian infants. J Infect Dis. 2016;213:1678–1685. Epub 2016/01/30.
   PubMed Web of Science ®Google Scholar
• Ali SA, Kazi AM, Cortese MM, et al. Impact of different dosing schedules on the immunogenicity of the human rotavirus vaccine in infants in Pakistan: a randomized trial. J Infect Dis. 2014;210:1772–1779. Epub 2014/06/19.
   PubMed Web of Science ®Google Scholar
• Bines JE, Danchin M, Jackson P, et al. Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2015;15:1389–1397. Epub 2015/09/01.
   PubMed Web of Science ®Google Scholar
• Mwenda JM, Tate JE, Parashar UD, et al. African rotavirus surveillance network: a brief overview. Pediatr Infect Dis J. 2014;33(Suppl 1):S6–8. Epub 2013/12/18.
   PubMed Web of Science ®Google Scholar